Amwell price target lowered to $15 from $40 at Wells Fargo

Wells Fargo lowered the firm’s price target on Amwell to $15 from $40 and keeps an Equal Weight rating on the shares. The firm is updating its model for Q2 results and recently announced reverse stock split. Wells factors some directional improvement on costs but top-line expectations remain almost unchanged.